Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia (PRFM-1)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03133455|
Recruitment Status : Recruiting
First Posted : April 28, 2017
Last Update Posted : April 28, 2017
Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.
The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.
|Condition or disease||Intervention/treatment||Phase|
|Fibromyalgia||Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.||Not Applicable|
|Study Type :||Interventional|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia|
|Actual Study Start Date :||September 16, 2015|
|Estimated Primary Completion Date :||December 30, 2017|
|Estimated Study Completion Date :||December 30, 2017|
|Patient with Fibromyalgia||
Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
- Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire [ Time Frame: 1 hour ]Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03133455
|Contact: Eric SERRA, Drfirstname.lastname@example.org|
|CHU Amiens Picardie||Recruiting|
|Amiens, Picardie, France, 80054|
|Contact: Eric SERRA, Dr +33322668820 email@example.com|